Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-4.20	29.00	30.28
Graham Fair Price	31.74	23.45	17.80
PEG	-61.79	-0.04	0.09
Price/Book	9.91	1.89	1.72
Price/Cash Flow	102.30	78.89	39.00
Prices/Earnings	-34.06	9.68	-14.68
Price/Sales	19.48	5.40	4.52
Price/FCF	102.30	78.89	39.00
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	8.12	0.47	0.44
Operating Margin	26.13	0.23	0.18
ROA	70.17	0.01	< 0.005
ROE	-0.03	0.05	66.70
ROIC	0.03	0.03	-25.99
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	0.02	-76.30
Dividends QOQ	0.02	< 0.005	-97.34
EBIT QOQ	-0.15	0.18	21.99
EPS QOQ	-1.57	2.70	72.57
FCF QOQ	-0.39	-0.45	-14.09
Revenue QOQ	0.05	-0.06	13.67
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	9.40	10.79	14.80
Days Sales Outstanding (DSO)	64.27	70.57	9.81
Inventory Turnover	9.58	8.34	-12.89
Debt/Capitalization	0.65	0.60	-8.57
Quick Ratio	0.51	0.55	8.14
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	21.93	22.38	2.04
Cash	0.49	0.88	80.34
Capex	-1.09	-1.14	-4.80
Free Cash Flow	0.97	0.54	-44.56
Revenue	8.34	7.82	-6.14
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.69	0.66	-5.17
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	15.78	14.24	-9.73
Naive Interpretation	Member

06 - Financial Health · Bad

Rating